摘要 |
The present invention provides isolated and purified polynucleotides, polypeptides, and antibodies related to mammalian (e.g., mouse and human) legumain and the novel legumain splice variant, ZB-I. The invention further relates to the use of these isolated and purified polynucleotides, polypeptides, and antibodies, as well as other legumain and ZB-I agonists and antagonists, in modulating legumain and/or ZB-I activity, expression, and/or secretion in a cell or cell population, e.g., monocytes, macrophages, foam cells, vascular endothelial cells, kidney proximal tubule cells, arterial endothelial cells, sites of inflammatory cell invasion into a vessel intima, and neointimal lesional areas of an artery. The invention also provides legumain and ZB-I antagonists, e.g., antagonistic small molecules, antibodies and antibody fragments to legumain and ZB-I, legumain and ZB-I inhibitory polypeptides, and legumain and ZB-I inhibitory polynucleotides. The present invention is also directed to novel methods for diagnosing, prognosing, monitoring, treating, ameliorating and/or preventing vascular disorders / diseases and inflammatory disorders / diseases.
|
申请人 |
WYETH;CLERIN, VALERIE;SHIH, HEATHER, H.;SHIELDS, KATHLEEN;FELDMAN, JEFFREY;HEBERT, GUSTAVE, T.;PITTMAN, DEBRA, D.;DENG, NANHUA DAN |
发明人 |
CLERIN, VALERIE;SHIH, HEATHER, H.;SHIELDS, KATHLEEN;FELDMAN, JEFFREY;HEBERT, GUSTAVE, T.;PITTMAN, DEBRA, D.;DENG, NANHUA DAN |